In the News

1548 News Items found
Andrea Barrio, a breast cancer surgeon at Memorial Sloan Kettering Cancer Center, talks to a patient
Important New Insights into Lymphedema: High Risk, Race, and Ethnicity
Learn about research on lymphedema at Memorial Sloan Kettering Cancer Center, which finds that Black and Hispanic women are at highest risk.
Dr. Sergio Giralt
Improving Treatment for Recurrent Multiple Myeloma With Ide-Cel CAR T Therapy
In this Q&A, MSK hematologic oncologist Sergio Giralt, MD, talks about a phase 3 trial of ide-cel CAR T therapy for people with recurrent multiple myeloma and what it may mean for people with this hard-to-treat blood cancer.
woman getting vaccine from doctor
HPV Vaccine Age Limit: You Might Not Be Too Old — What You Should Know
Learn from MSK experts what people over 26 should know about getting the HPV vaccine to protect themselves from several forms of cancer.
Tobias M. Hohl, MD, PhD
Tobias M. Hohl Elected a 2022 AAAS Fellow
Tobias M. Hohl, MD, PhD, Chief of the Infectious Diseases Service in the Department of Medicine, was elected a 2022 Fellow of the American Association for the Advancement of Science (AAAS), the world’s largest scientific society and publisher of the Science journals. This title is one of the most distinguished honors within the scientific community and is designed to recognize leaders for their notable contributions to science.
Patient Mary Oehrlein at her Long Island home near MSK Commack, where a diagnostic biopsy test identified the best treatment for her pancreatic cancer
Start Your Cancer Treatment Fast With MSK's Rapid Diagnosis
The day before Thanksgiving, Mary Oehrlein got the earth-shattering news. She’d had some tests at her local hospital to see what was causing her stomac...
Dr. Selwyn Vickers seen outdoors with his wife, Janice, and their four children.
Black History Seen Through the Remarkable Family of Dr. Selwyn Vickers
Experience a remarkable portrait of Black history in America through the family story of Dr. Selwyn Vickers, the President and CEO of Memorial Sloan Kettering Cancer Center.
Robin Bankins
FDA Approves First Treatment for Patients With All Forms of Histiocytosis
Based a clinical trial conducted at MSK, the FDA has approved the targeted drug cobimetinib (Cotellic®) for treating a rare group of diseases known as histiocytoses, or histiocytic neoplasms in adults.
MSK multiple myeloma specialist Sham Mailankody
Off-the-Shelf CAR T Cell Therapy for Multiple Myeloma Shows Promise
A new type of CAR T cell therapy for multiple myeloma could shorten the time to treatment.
detail shot of a scientist pipetting in a lab
MSK Research Highlights, January 20, 2023
New research from MSK explores novel predictors of immunotherapy effectiveness against lung cancer; identifies how a high-fat diet hinders intestinal damage repair; reports findings from a clinical trial for people with androgen receptor-positive salivary gland cancer; and aims to understand the impact of tumor mutational burden on patients with locally advanced non-small cell lung cancer.
MSK hematological oncologist Lindsey Roeker
Meet Chronic Lymphocytic Leukemia Expert Lindsey Roeker
Meet hematologic oncologist Lindsey Roeker and learn why people who have been diagnosed with chronic lymphocytic leukemia should come to MSK.